• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑淀粉样血管病负担与脑微出血:不同表型的病理证据。

Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes.

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

出版信息

J Alzheimers Dis. 2021;81(1):113-122. doi: 10.3233/JAD-201536.

DOI:10.3233/JAD-201536
PMID:33720897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113155/
Abstract

BACKGROUND

The relationship between cerebral microbleeds (CMBs) on hemosiderin-sensitive MRI sequences and cerebral amyloid angiopathy (CAA) remains unclear in population-based participants or in individuals with dementia.

OBJECTIVE

To determine whether CMBs on antemortem MRI correlate with CAA.

METHODS

We reviewed 54 consecutive participants with antemortem T2*GRE-MRI sequences and subsequent autopsy. CMBs were quantified on MRIs closest to death. Autopsy CAA burden was quantified in each region including leptomeningeal/cortical and capillary CAA. By a clustering approach, we examined the relationship among CAA variables and performed principal component analysis (PCA) for dimension reduction to produce two scores from these 15 interrelated predictors. Hurdle models assessed relationships between principal components and lobar CMBs.

RESULTS

MRI-based CMBs appeared in 20/54 (37%). 10 participants had ≥2 lobar-only CMBs. The first two components of the PCA analysis of the CAA variables explained 74% variability. The first rotated component (RPC1) consisted of leptomeningeal and cortical CAA and the second rotated component of capillary CAA (RPC2). Both the leptomeningeal and cortical component and the capillary component correlated with lobar-only CMBs. The capillary CAA component outperformed the leptomeningeal and cortical CAA component in predicting lobar CMBs. Both capillary and the leptomeningeal/cortical components correlated with number of lobar CMBs.

CONCLUSION

Capillary and leptomeningeal/cortical scores correlated with lobar CMBs on MRI but lobar CMBs were more closely associated with the capillary component. The capillary component correlated with APOEɛ4, highlighting lobar CMBs as one aspect of CAA phenotypic diversity. More CMBs also increase the probability of underlying CAA.

摘要

背景

在基于人群的参与者或痴呆患者中,磁共振成像(MRI)序列上的脑微出血(CMBs)与脑淀粉样血管病(CAA)之间的关系尚不清楚。

目的

确定MRI 上的 CMBs 是否与 CAA 相关。

方法

我们回顾了 54 例连续接受 MRI 检查的患者,这些患者生前进行了 T2*GRE-MRI 序列检查,并随后进行了尸检。在与死亡时间最接近的 MRI 上对 CMBs 进行定量分析。对包括软脑膜/皮质和毛细血管 CAA 在内的每个区域的 CAA 负担进行定量分析。通过聚类方法,我们检查了 CAA 变量之间的关系,并对这些 15 个相互关联的预测因子进行主成分分析(PCA)以进行降维,从而从这些预测因子中产生两个得分。障碍模型评估了主要成分与脑叶 CMBs 之间的关系。

结果

MRI 上的 CMBs 出现在 20/54 例(37%)患者中。10 例患者存在≥2 个脑叶仅有 CMBs。CAA 变量的 PCA 分析的前两个成分解释了 74%的变异性。第一旋转成分(RPC1)由软脑膜和皮质 CAA 组成,第二旋转成分由毛细血管 CAA(RPC2)组成。软脑膜和皮质成分以及毛细血管成分均与脑叶仅有 CMBs 相关。毛细血管 CAA 成分在预测脑叶 CMBs 方面优于软脑膜和皮质 CAA 成分。毛细血管和软脑膜/皮质成分均与脑叶 CMBs 的数量相关。

结论

毛细血管和软脑膜/皮质评分与 MRI 上的脑叶 CMBs 相关,但脑叶 CMBs 与毛细血管成分的相关性更强。毛细血管成分与 APOEɛ4 相关,突出了脑叶 CMBs 是 CAA 表型多样性的一个方面。更多的 CMBs 也增加了潜在 CAA 的可能性。

相似文献

1
Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes.脑淀粉样血管病负担与脑微出血:不同表型的病理证据。
J Alzheimers Dis. 2021;81(1):113-122. doi: 10.3233/JAD-201536.
2
Histopathological Correlates of Lobar Microbleeds in False-Positive Cerebral Amyloid Angiopathy Cases.脑淀粉样血管病假阳性病例中微出血灶的组织病理学相关性
Ann Neurol. 2023 Nov;94(5):856-870. doi: 10.1002/ana.26761. Epub 2023 Sep 6.
3
Cortical localization of microbleeds in cerebral amyloid angiopathy: an ultra high-field 7T MRI study.脑淀粉样血管病中微出血的皮质定位:一项超高场7T磁共振成像研究
J Alzheimers Dis. 2015;43(4):1325-30. doi: 10.3233/JAD-140864.
4
Cortical microinfarcts in patients with multiple lobar microbleeds on 3 T MRI.3T MRI 上多发性脑叶微出血患者的皮质微梗死。
J Neurol. 2019 Aug;266(8):1887-1896. doi: 10.1007/s00415-019-09350-9. Epub 2019 May 2.
5
Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds.认知功能下降伴混合性脑微出血患者的高血压性血管病变和脑淀粉样血管病。
J Alzheimers Dis. 2020;78(4):1765-1774. doi: 10.3233/JAD-200992.
6
Infratentorial Cerebral Microbleeds in Patients with Cerebral Amyloid Angiopathy.脑淀粉样血管病患者的幕下脑微出血
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2534-2537. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.015. Epub 2018 May 31.
7
Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration.脑微出血、脑淀粉样血管病及其与神经退行性变定量标志物的关系。
Neurology. 2022 Apr 19;98(16):e1605-e1616. doi: 10.1212/WNL.0000000000200142. Epub 2022 Feb 28.
8
Amyloid Angiopathy in Brain Hemorrhage: A Postmortem Neuropathological-Magnetic Resonance Imaging Study.脑出血中的淀粉样血管病:一项尸检神经病理学-磁共振成像研究
Cerebrovasc Dis. 2018;45(3-4):124-131. doi: 10.1159/000486554. Epub 2018 Mar 20.
9
Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events.表现为轻微脑血管事件的患者的脑微出血和皮质浅表性铁沉积症
Stroke. 2016 Sep;47(9):2236-41. doi: 10.1161/STROKEAHA.116.013418. Epub 2016 Aug 9.
10
Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.使用3.0特斯拉尸检磁共振图像和组织病理学对皮质微梗死和微出血进行对比分析
J Alzheimers Dis. 2017;59(3):951-959. doi: 10.3233/JAD-161242.

引用本文的文献

1
Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage.脑淀粉样血管病的临床特征及脑淀粉样血管病相关性脑出血的危险因素
J Neurol. 2024 Aug;271(8):5025-5034. doi: 10.1007/s00415-024-12451-9. Epub 2024 May 26.
2
Relationship between morning blood pressure variability and cerebral microbleed burden in patients with hypertension.高血压患者清晨血压变异性与脑微出血负荷的关系。
J Clin Hypertens (Greenwich). 2024 Jun;26(6):665-673. doi: 10.1111/jch.14831. Epub 2024 May 22.
3
Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.

本文引用的文献

1
Neuropathological correlates of cortical superficial siderosis in cerebral amyloid angiopathy.脑淀粉样血管病皮质浅铁沉积的神经病理学相关性。
Brain. 2020 Dec 5;143(11):3343-3351. doi: 10.1093/brain/awaa266.
2
Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions.脑血管病影像学病变的流行率和异质性。
Mayo Clin Proc. 2020 Jun;95(6):1195-1205. doi: 10.1016/j.mayocp.2020.01.028.
3
Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging.脑微出血发生率与淀粉样蛋白负荷的关系:明尼苏达州老龄化研究。
波士顿标准 2.0 用于无出血性脑淀粉样血管病:一项 MRI-神经病理学验证研究。
Neurology. 2024 May 28;102(10):e209386. doi: 10.1212/WNL.0000000000209386. Epub 2024 May 6.
4
Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages.动脉粥样硬化负担与脑小血管病:通过微血管老化和脑微出血探索其关联。
Geroscience. 2024 Oct;46(5):5103-5132. doi: 10.1007/s11357-024-01139-7. Epub 2024 Apr 19.
5
Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.两种非典型阿尔茨海默病变异体的行为和神经精神差异:进行性非流利性失语症和后部皮质萎缩。
J Alzheimers Dis. 2024;97(2):895-908. doi: 10.3233/JAD-230652.
6
Relation of MRI-Visible Perivascular Spaces and Other MRI Markers of Cerebral Small Vessel Disease.脑小血管病的MRI可见血管周围间隙与其他MRI标志物的关系。
Brain Sci. 2023 Sep 14;13(9):1323. doi: 10.3390/brainsci13091323.
7
Imaging the time course, morphology, neuronal tissue compression, and resolution of cerebral microhemorrhages in mice using intravital two-photon microscopy: insights into arteriolar, capillary, and venular origin.利用活体双光子显微镜观察小鼠脑微出血的时程、形态、神经元组织压迫和分辨率:对小动脉、毛细血管和小静脉起源的深入了解。
Geroscience. 2023 Oct;45(5):2851-2872. doi: 10.1007/s11357-023-00839-w. Epub 2023 Jun 20.
8
Cerebrovascular disease lesions are additive and tied to vascular risk factors and cognitive impairment.脑血管疾病病变具有累积性,且与血管危险因素和认知障碍相关。
Free Neuropathol. 2022;3:7. doi: 10.17879/freeneuropathology-2022-3792. Epub 2022 Mar 14.
9
Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.血浆淀粉样蛋白、tau 蛋白和神经退行性变生物标志物与脑微出血的关系。
J Alzheimers Dis. 2022;87(4):1537-1547. doi: 10.3233/JAD-220158.
10
Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee.阿杜卡努单抗在症状性阿尔茨海默病中的应用:AAN 指南小组委员会的报告。
Neurology. 2022 Apr 12;98(15):619-631. doi: 10.1212/WNL.0000000000200176. Epub 2022 Feb 23.
Neurology. 2020 Jan 14;94(2):e190-e199. doi: 10.1212/WNL.0000000000008735. Epub 2019 Dec 4.
4
Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging.老年人凸面蛛网膜下腔出血的发生率:明尼苏达州梅奥诊所的老龄化研究。
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104451. doi: 10.1016/j.jstrokecerebrovasdis.2019.104451. Epub 2019 Oct 24.
5
Cerebral microbleeds: Prevalence and relationship to amyloid burden.脑微出血:患病率与淀粉样蛋白负担的关系。
Neurology. 2019 Jan 15;92(3):e253-e262. doi: 10.1212/WNL.0000000000006780. Epub 2018 Dec 19.
6
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.急性缺血性卒中和短暂性脑缺血发作(TIA)后接受抗凝治疗的房颤患者的脑微出血和颅内出血风险(CROMIS-2):一项多中心观察性队列研究。
Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
7
Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.脑淀粉样血管病的诊断:波士顿标准的演变
Stroke. 2018 Feb;49(2):491-497. doi: 10.1161/STROKEAHA.117.016990. Epub 2018 Jan 15.
8
Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.浅表性铁沉积症的患病率及自然史:一项基于人群的研究。
Stroke. 2017 Dec;48(12):3210-3214. doi: 10.1161/STROKEAHA.117.018974. Epub 2017 Oct 25.
9
Emerging concepts in sporadic cerebral amyloid angiopathy.散发性脑淀粉样血管病的新观念
Brain. 2017 Jul 1;140(7):1829-1850. doi: 10.1093/brain/awx047.
10
Association of Cerebral Microbleeds With Cognitive Decline and Dementia.脑微出血与认知能力下降和痴呆的关系。
JAMA Neurol. 2016 Aug 1;73(8):934-43. doi: 10.1001/jamaneurol.2016.1017.